Collegium Pharmaceutical, Inc. (COLL)
22.70
-0.22
(-0.94%)
USD |
NASDAQ |
Sep 11, 14:42
Collegium Pharmaceutical Gross Profit (TTM) : 485.09M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 485.09M |
| March 31, 2026 | 483.18M |
| December 31, 2025 | 463.26M |
| September 30, 2025 | 433.17M |
| June 30, 2025 | 400.79M |
| March 31, 2025 | 383.21M |
| December 31, 2024 | 377.34M |
| September 30, 2024 | 373.69M |
| June 30, 2024 | 357.20M |
| March 31, 2024 | 340.22M |
| December 31, 2023 | 326.17M |
| September 30, 2023 | 286.11M |
| June 30, 2023 | 264.64M |
| March 31, 2023 | 243.18M |
| December 31, 2022 | 214.27M |
| September 30, 2022 | 158.37M |
| June 30, 2022 | 145.64M |
| March 31, 2022 | 143.52M |
| December 31, 2021 | 150.62M |
| September 30, 2021 | 196.24M |
| June 30, 2021 | 198.32M |
| March 31, 2021 | 196.45M |
| December 31, 2020 | 179.84M |
| Date | Value |
|---|---|
| September 30, 2020 | 160.66M |
| June 30, 2020 | 138.65M |
| March 31, 2020 | 116.68M |
| December 31, 2019 | 103.04M |
| September 30, 2019 | 121.63M |
| June 30, 2019 | 119.61M |
| March 31, 2019 | 119.44M |
| December 31, 2018 | 114.74M |
| September 30, 2018 | 80.74M |
| June 30, 2018 | 67.96M |
| March 31, 2018 | 44.72M |
| December 31, 2017 | 25.88M |
| September 30, 2017 | 17.00M |
| June 30, 2017 | 5.714M |
| March 31, 2017 | 2.687M |
| December 31, 2016 | 0.843M |
| September 30, 2016 | -0.022M |
| June 30, 2016 | -0.166M |
| March 31, 2016 | -0.168M |
| December 31, 2015 | -0.171M |
| September 30, 2015 | -0.13M |
| June 30, 2015 | -0.092M |
| March 31, 2015 | -0.046M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Innoviva, Inc. | 317.57M |
| Zevra Therapeutics, Inc. | 128.53M |
| Supernus Pharmaceuticals, Inc. | 629.69M |
| Indivior Pharmaceuticals, Inc. | 1.116B |
| Crinetics Pharmaceuticals, Inc. | 36.49M |